‘There are no known risks,’ one expert says, ‘because no one has looked.’
Industry critics worry that unregulated providers are overprescribing the drugs, glossing over potential hazards and failing to properly report problems when they arise. One recently published study, for example, blamed “increasingly aggressive treatment protocols” for incidents of OHSS, while another argued that most cases are completely “avoidable.”